2010
DOI: 10.1016/j.humpath.2009.07.002
|View full text |Cite
|
Sign up to set email alerts
|

Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
50
2
1

Year Published

2011
2011
2017
2017

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 87 publications
(57 citation statements)
references
References 50 publications
3
50
2
1
Order By: Relevance
“…This immunohistochemical profile is similar to that of normal urothelium. Similar pattern is reported by Hodges et al (1) . This finding supported that flat hyperplasia does not have a premalignant potential…”
Section: Significance Of Flat Epithelial Lesions Of the ………supporting
confidence: 91%
See 2 more Smart Citations
“…This immunohistochemical profile is similar to that of normal urothelium. Similar pattern is reported by Hodges et al (1) . This finding supported that flat hyperplasia does not have a premalignant potential…”
Section: Significance Of Flat Epithelial Lesions Of the ………supporting
confidence: 91%
“…It is the fourth most common cancer in men, accounting for 6.9% of all cancers, and tenth most common cancer in women, accounting for 2.6% of all cancers (1) . In Egypt, it constitutes 30.3% of all cancers (2) .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Numerous promising novel biomarkers have been investigated during the last couple of years [8] , but only very few markers have been validated in prospective trials [9] . Until now, only immunohistochemical staining of p53 found its way into pathological routine diagnostics for selected cases [10,11] . Since high-grade and invasive tumors ( 6 pT1) in particular are characterized by their invasive potential and ability to metastasize, this study focuses on two key players that are well known to orchestrate tissue invasion by tissue degrading MMPs: the MMP inhibitor RECK and the activating counterpart EMMPRIN (also known as CD147).…”
Section: Introductionmentioning
confidence: 99%
“…The identification of TP53 mutations in slightly transformed cells (e.g. the unusual frequency of A > T transversions in p53 [−] IHC areas) supports the postulate of field cancerization consecutive to AA exposure and the hypothesis that A > T transversion in TP53 is one of the earliest events in AA-induced urothelial carcinogenesis, followed by a later occurrence and a progressive accumulation of additional genetic alterations [42].…”
Section: Discussionmentioning
confidence: 54%